Bupropion for Depression in ESRD Patients on Hemodialysis

Trial Profile

Bupropion for Depression in ESRD Patients on Hemodialysis

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 03 Oct 2016

At a glance

  • Drugs Bupropion (Primary) ; Fluoxetine
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Sep 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 26 Sep 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Aug 2017.
    • 16 Sep 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Aug 2016, as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top